NDC00641-6018-01: DOXAPRAM HYDROCHLORIDE INJECTION.
DOXAPRAM HYDROCHLORIDE INJECTION. Key specifications include administration: INTRAVENOUS, primary_container_type: VIAL, MULTIPLE DOSE, medical_designation_and_grade: UNITED STATES PHARMACOPEIA, primary_container_content_quantity: 20.0 MILLILITERS, active_medicament_medicinal_strength: 20.0 MILLIGRAMS DOXAPRAM HYDROCHLORIDE EQUIVALENT PER MILLILITER, part_name_assigned_by_controlling_agency: DOXAPRAM HYDROCHLORIDE INJECTION, USP 400MG/20ML, VIAL. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-716-5873, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAVENOUS |
| primary_container_type | VIAL, MULTIPLE DOSE |
| medical_designation_and_grade | UNITED STATES PHARMACOPEIA |
| primary_container_content_quantity | 20.0 MILLILITERS |
| active_medicament_medicinal_strength | 20.0 MILLIGRAMS DOXAPRAM HYDROCHLORIDE EQUIVALENT PER MILLILITER |
| part_name_assigned_by_controlling_agency | DOXAPRAM HYDROCHLORIDE INJECTION, USP 400MG/20ML, VIAL |
| NSN | 6505-01-716-5873 |
| ADMINISTRATION | INTRAVENOUS |
| PRIMARY CONTAINER CONTENT QUANTITY | 20.0 MILLILITERS |
| MEDICAL DESIGNATION AND GRADE | UNITED STATES PHARMACOPEIA |
| PRIMARY CONTAINER TYPE | VIAL, MULTIPLE DOSE |
| SPECIAL FEATURES | DOXAPRAM HYDROCHLORIDE INJECTION, USP; 20 ML MULTIPLE DOSE VIAL CONTAINING 20 MG OF DOXAPRAM HYDROCHLORIDE PER ML WITH BENZYL ALCOHOL 0.9% AS THE PRESERVATIVE; STORE AT CONTROLLED ROOM TEMPERATURE, BETWEEN 20 TO 25 DEG C (68 TO 77 DEG F); NOT FOR USE IN NEONATES; CONTAINS BENZYL ALCOHOL; FOR INTRAVENOUS ADMINISTRATION. DEGC |
| PART NAME ASSIGNED BY CONTROLLING AGENCY | DOXAPRAM HYDROCHLORIDE INJECTION, USP 400MG/20ML, VIAL |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 20.0 MILLIGRAMS DOXAPRAM HYDROCHLORIDE EQUIVALENT PER MILLILITER |